Skip to main content

Risk Assessment and Control on Vaccine-Preventable Diseases

  • Chapter
  • First Online:
Prevention and Control of Infectious Diseases in BRI Countries
  • 256 Accesses

Abstract

Poliomyelitis (polio) is a highly infectious intestinal disease caused by the poliovirus. Poliovirus is transmitted by person-to-person spread mainly through the fecal–oral route, or, less frequently, by contaminated water or food. Humans are the only known reservoir of poliovirus, which is transmitted most frequently by persons with inapparent infections. Initial symptoms of polio include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. In a small proportion of cases (1 in 200 infections), poliovirus causes paralysis, which is often permanent. Instead of a cure for polio, it can only be prevented. The Polio vaccine, given multiple times, can protect a child for life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO. Poliomyelitis. https://www.who.int/en/news-room/fact-sheets/detail/poliomyelitis. 2019.

  2. Greene SA, Ahmed J, Datta SD, et al. Progress toward polio eradication—worldwide, January 2017–March 2019. MMWR. 2019;68(20):458–62.

    PubMed  PubMed Central  Google Scholar 

  3. WHO. Poliomyelitis disease outbreak news. https://www.who.int/csr/don/archive/disease/poliomyelitis/en/. 2019.

  4. WHO. Immunization, Vaccines and Biologicals. https://www.who.int/immunization/monitoring_surveillance/data/en/. 2019.

  5. Global Polio Eradication Initiative. Key At-Risk Countries. http://polioeradication.org/where-we-work/key-at-risk-countries/. 2019.

  6. National Health and Family Planning Commission. PRC, Poliomyelitis Diagnosis (WS 294-2016). 2016.

    Google Scholar 

  7. Luo HM, Zhang Y, Wang XQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981–90.

    Article  CAS  Google Scholar 

  8. Wenzhou Y, Wushouer F, Haibo W, et al. Experience and lessons learned from the investigation of and response to imported wild poliovirus causing local transmission in Xinjiang Uygur Autonomous Region in 2011. Chin J Vac Immuniz. 2013;19(04):361–4.

    Google Scholar 

  9. WHO. Standard operating procedures; Responding to a poliovirus event or outbreak version, vol. 3. Geneva: World Health Organization; 2018.

    Google Scholar 

  10. WHO. Measles. https://www.who.int/immunization/diseases/measles/en/. 2019.

  11. WHO. Measles—Global situation. https://www.who.int/csr/don/26-november-2019-measles-global_situation/en/. 2019.

  12. Chinese Center for Disease Control and Prevention. Knowledge of measles prevention and control. Aust Health Rev. 2017;2:63.

    Google Scholar 

  13. WHO. WHO recommended strategies for the prevention and control of communicable diseases. Geneva: WHO Press; 2001.

    Google Scholar 

  14. National Health Commission. PRC, Diagnosis of Epidemic Cerebrospinal Meningitis (WS 295-2019). 2019.

    Google Scholar 

  15. GBD. 2015 Disease and Injury Incidence and Prevalence Collaborators. Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.

    Article  Google Scholar 

  16. Epidemic meningitis control in countries of the. African meningitis belt, 2018. Wkly Epidemiol Rec. 2019;94(14/15):169–88.

    Google Scholar 

  17. Yoshikawa H, Ebihara K, Tanaka Y, et al. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years. Cancer Sci. 2013;104(4):465–72.

    Article  CAS  Google Scholar 

  18. Ministry of Health, PRC. National Program for Epidemic Cerebrospinal Meningitis Prevention and Control (CDC [2006] No. 32). 2006.

    Google Scholar 

  19. Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93(4):341–53.

    Article  CAS  Google Scholar 

  20. Yixing L, Junhong L, Zundong Y, et al. Surveillance and control of epidemic Japanese encephalitis. Chin J Plan Immuniz. 2006;6:527–32.

    Google Scholar 

  21. Fischer M, Lindsey N, Staples JE, et al. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(RR-1):1–27.

    PubMed  Google Scholar 

  22. Instructions for the Prevention and Control of. Epidemic Japanese Encephalitis. Chin J Plan Immuniz. 2004;4:63–4.

    Google Scholar 

  23. Guoqiang W. Disease prevention and control in China 1955–2015. Beijing: China Population Publishing House; 2015.

    Google Scholar 

  24. Centers for Disease Control and Prevention. Yellow book 2020: health information for international travel. New York: Oxford University Press; 2017.

    Google Scholar 

  25. WHO. Hepatitis A. https://www.who.int/immunization/diseases/hepatitisA/en/. 2019.

  26. Epidemiological update: hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men. https://www.ecdc.europa.eu/en/news-events/epidemiological-update-hepatitis-outbreak-eueea-mostly-affecting-men-who-have-sex-men-0. 2017.

  27. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–7.

    Article  Google Scholar 

  28. Fiore AE, Wasley A, Bell BP, et al. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(Rr-7):1–23.

    PubMed  Google Scholar 

  29. Collier MG, Khudyakov YE, Selvage D, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014;14(10):976–81.

    Article  Google Scholar 

  30. State of Hawaii, Department of Health. Hepatitis A Outbreak 2016. http://health.hawaii.gov/docd/hepatitis-a-outbreak-2016/. 2016.

  31. CDC. Outbreak of hepatitis A in Hawaii linked to raw scallops. https://www.cdc.gov/hepatitis/outbreaks/2016/hav-hawaii.htm. 2016.

  32. Foster M, Ramachandran S, Myatt K, et al. Hepatitis A virus outbreaks associated with drug use and homelessness—California, Kentucky, Michigan, and Utah, 2017. MMWR. 2018;67(43):1208–10.

    PubMed  PubMed Central  Google Scholar 

  33. Latash J, Dorsinville M, Del Rosso P, et al. Notes from the field: increase in reported hepatitis A infections among men who have sex with men—New York City, January–August 2017. MMWR. 2017;66(37):999–1000.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huiming Luo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Su, Q., Ning, G., Luo, H. (2021). Risk Assessment and Control on Vaccine-Preventable Diseases. In: Yang, W. (eds) Prevention and Control of Infectious Diseases in BRI Countries. Springer, Singapore. https://doi.org/10.1007/978-981-33-6958-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-33-6958-0_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-33-6957-3

  • Online ISBN: 978-981-33-6958-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics